Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-14

Clinical Trial Update: Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury

View source ↗

Summary

A completed observational study update evaluating possible links between serotonin-norepinephrine reuptake inhibitors and acute kidney injury in people with dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serotonin-norepinephrine reuptake inhibitor (SNRI) class

Snippet

Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES | Conditions: Depression, Acute Kidney Injury | Status: COMPLETED